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Abstract
Background: Celiac ganglia (CG) can be seen by endoscopic ultrasound; they play an important
role in pain management and are a potential site for extrapancreatic tumor neural invasion.
Aims: To evaluate the frequency of CG visualization during endoscopic ultrasound examina-
tion and to evaluate the feasibility of this technique to identify extrapancreatic tumor neural
invasion in patients with pancreatic lesions.
Methods: We retrospectively reviewed all endoscopic ultrasound studies performed between
November 2007 and June 2010. Images of the celiac region were presented to an endosonogra-
pher, who reported the presence or absence of CG.
Results: We included 31 cases. CG were identiﬁed in 14 (45%) cases. Average size was 10mm
(range 4-25mm) by± 1mm (range 1-7mm). In 2 cases, ﬁne needle aspiration biopsy was per-
formed and reported nerve cell bodies; in one case malignant cells were seen.
Conclusions: CG were identiﬁed in 45% of the cases. Fine needle aspiration biopsy can detect
unanticipated extrapancreatic tumor neural invasion in pancreatic malignancies.
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PALABRAS CLAVE
Ultrasonido
endoscópico;
Quiste pancreático;
Invasión neural;
Ganglios celiacos
Frecuencia de visualización de ganglios celíacos por ultrasonido endoscópico y su
potencial en la evaluación de invasión neural en pacientes con lesiones pancreáticas
Resumen
Antecedentes: Los ganglios celíacos (GC) pueden ser visualizados por ultrasonido endoscópico;
juegan un papel importante en el manejo del dolor y son un sitio potencial de invasión tumoral
neural extrapancreática.
Objetivos: Evaluar la frecuencia de visualización de los GC durante el examen de ultrasonido
endoscópico, así como la factibilidad de este para identiﬁcar la invasión tumoral neural extra-
pancreática en pacientes con lesiones pancreáticas.
Métodos: Revisamos retrospectivamente todos los estudios de ultrasonido endoscópico que se
llevaron a cabo desde noviembre de 2007 a junio de 2010. Las imágenes de la región celíaca se
presentaron a un endosonograﬁsta, quien reportó la presencia o ausencia de GC.
Resultados: Incluimos 31 casos. Se identiﬁcaron GC en 14 (45%) de los casos. El taman˜o promedio
fue de 10mm (rango 4-25mm) por± 1mm (rango 1-7mm). En 2 casos se llevó a cabo una
biopsia por aspiración con aguja ﬁna y se reportaron cuerpos de células neurales; en un caso se
observaron células malignas.
Conclusiones: Se identiﬁcaron GC en el 45% de los casos. La biopsia por aspiración con aguja
ﬁna puede detectar invasión tumoral neural extrapancreática inesperada en neoplasias pan-
creáticas.
© 2013 Asociación Mexicana de Gastroenterología. Publicado por Masson Doyma México S.A.
Todos los derechos reservados.
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Sntroduction
he celiac plexus contains the celiac ganglia (CG), which have been
f anatomical and clinical interest in chronic pancreatitis and pan-
reatic cancer due to their role in pain management1,2 and as a
otential site for tumor invasion.3
The celiac plexus is located at the level of T12 and L1, anterior
o the diaphragmatic crura, medial to the adrenal glands, and close
o the aorta between the origin of the celiac trunk and the superior
esenteric artery.4
The CG can be visualized in up to 80% of the endoscopic ultra-
ound (EUS) examinations. However, this number varies among
ublications, depending on endosonographer experience, type of
choendoscope used, and on patient-related factors. The CG are
est seen with curved linear array echoendoscopes and in female
ubjects with no prior history of abdominal surgery.5
Visualization of CG by EUS6 has allowed for direct injection into
ndividual CG to perform blocks or neurolysis in patients with pan-
reatic disorders suffering from intractable pain.5,7] In addition,
xtrapancreatic neural invasion (EPNI) involving CG in cases with
ancreatic malignancy has been identiﬁed.8
During EUS examination, the CG appear as oblong or round
ypoechoic structures, with jagged edges containing hyperechoic
oci or strands. Their average size ranges from 2 to 20mm.7
We report herein the frequency of visualization of CG by EUS
sing the previously published endosonographic features5--7 and the
dentiﬁcation of microscopic EPNI by EUS-guided ﬁne needle aspi-
ation (FNA) in patients with pancreatic lesions.
ethods
e retrospectively reviewed our database for patients that
ad been referred for EUS examination of pancreatic lesions
etween November 2007 and March 2010. We identiﬁed 81
ases, but the images from 50 cases were lost during main-
enance of our storage system, so 31 cases with available
mages or video clips from the celiac region were ﬁnally
a
a
t
ancluded; clinical and demographic data were recorded.
single expert endosonographer (MPL) performed all the
tudies using a linear-curve array (GF-UC140P-AL5; Olympus
merica Inc, Center Valley, PA) echoendoscope.
All patients gave their informed consent for the pro-
edure and received sedation with propofol under strict
onitoring by an anesthesiologist.
The presence of CG was determined by identifying char-
cteristic endosonographic patterns according to previous
escriptions,6,8,9 located on the sides of the emergence of
he celiac artery and/or if FNA from that structure showed
erve cell bodies without lymphocytes.
Images and videos from each case were coded and
orted randomly and shown to the endosonographer, who
as blinded to the exam report and ﬁndings; he reported
he presence or absence of CG, in addition to providing a
etailed description of the observed structures.
In order to avoid recall bias, we did not include images
rom cases performed within a time frame of 6 months
efore the study period.
esults
ndications for EUS were pancreatic masses with a ﬁnal diagnosis of
denocarcinoma (18 cases, 58%) and pancreatic cysts with EUS char-
cteristics suggestive of side branch intraductal papillary mucinous
eoplasm without worrisome characteristics (13 cases, 42%).
eliac ganglia
tructures consistent with CG were visualized between the celiac
rtery and left adrenal gland in 14 cases (45%); eight in benign cases
nd 6 in malignant ones. They appeared as elongated, slim struc-
ures that were mostly hypoechoic, with a slight hyperechoic center
nd irregular borders (ﬁg. 1A). The average size of the axis was
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Figure 1 A The blue arrow shows normal-looking celiac ganglia. B The blue arrow shows an enlarged CG. Fine needle aspiration
biopsy was performed due to suspicion of a metastatic celiac lymph node. C An enlarged CG cytologic examination showed a group
of three large, discohesive ganglion-like cells (blue arrows) neatly dispersed among small groups of adenocarcinoma cells (black
arrows). In a trained team setting, this kind of image can be conﬁdently interpreted as neoplastic inﬁltration into the nerve ganglia
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C(hematoxylin & eosin, x400).
10mm in length± 5mm (SD) (range 4-25mm) and the minor axis
was 3mm± 1mm (SD) (range 1mm-7mm).
Celiac ganglia biopsy
In two pancreatic mass cases, to exclude tumor metastasis, FNA
biopsy was performed on structures that, due to their EUS appear-
ance, were initially suspected of being celiac lymph nodes (ﬁg. 1B).
FNA caused transient pain, characterized by patient movement and
an increase in heart rate.
An in situ cytologic examination showed the presence of neural
bodies with no lymphocytes and surrounded by malignant cells in
one case (ﬁg. 1C), and only neural bodies with no lymphocytes or
malignant cells in another case.
Discussion
Abdominal pain related to chronic pancreatitis or pancreatic cancer
is usually secondary to anatomic and mechanical abnormalities;1,2
in cases without pancreatic anatomical changes, pain usually results
from inﬂammatory or neoplastic inﬁltration of intrapancreatic and
extrapancreatic pain afferents, including the celiac plexus. 3,8
EUS allows visualization of the celiac plexus ganglia in up to 80%
of cases; in our study, we visualized it in approximately 45% of the
cases. This could be related to detection errors from losing around
50 cases due to electronic and computer eventualities, using only
a linear array echoendoscope, the fact that only one endosonog-
rapher participated in the study, and that we based our ﬁndings
on descriptions given by other authors,6,7 rather than on histology
that could conﬁrm that we were actually observing CG. FNA of these
structures has precise indications: to perform intraganglionic block
or neurolysis; neither of these was the indication in any of our cases.
Nevertheless, 2 cases with diagnosis of pancreatic cancer under-
went CG FNA biopsy; this was performed under the initial suspicion
c
d
if metastatic disease to what appeared to be celiac lymph nodes.
urprisingly, cytologic examination revealed abundant neuronal
odies in both cases and accompanying malignant cells in one
atient. In the two cases, noises and movement of the patient,
hich ceased upon needle withdrawal, accompanied FNA. These
linical ﬁndings with the corresponding cytology are signs of nerve
tructure puncture. 3,8
The importance of visualizing the CG during EUS has been the
ubject of debate. Multiple reports,6,7 including a meta-analysis9
f patients with abdominal pain secondary to chronic pancreati-
is or pancreatic cancer, reported that EUS-guided neurolysis is an
ffective and safe method with better pain control rates, com-
ared with radiological methods; one of the studies included in
he meta-analysis performed intraganglionic celiac block and neu-
olysis in some patients with promising results; this led to the
dea that intraganglionic injection could be associated with better
esults, compared with the current technique, although numbers
nd follow-up were limited.5
Invasion and metastasis are key components of cancer progres-
ion. The most common tumor dissemination paths are blood and
ymphatic vessels. A distinct and overlooked path is perineural inva-
ion (PNI). PNI, deﬁned as the presence of cancer cells in the
erineural space, is frequently used by pancreatic and prostate
ancer and is associated with local recurrence and pain.3,8
Taking into consideration the reports suggesting that the celiac
lexus can be a potential site of metastasis in pancreatic cancer, as
ell as the fact that EPNI occurs more frequently than suspected,
nd is associated with poor prognosis and a higher risk of local tumor
ecurrence,10 suggesting that EPNI detection could modify its man-
gement, are all reasons why the identiﬁcation and sampling of the
G should be considered during the staging process of pancreatic
ancer.3,8
After the preliminary report of EPNI in pancreatic cancer
etected by EUS,8 this is the second study to report similar ﬁnd-
ngs, although in a single case. This limited information makes it
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ifﬁcult to determine the clinical relevance not only of locating the
eliac ganglia by EUS, but also of considering it as part of the staging
rocess in pancreatic cancer. Whether EPNI represents late stages
f the disease or can predict a higher rate of local recurrences in
ancreatic cancer remains unknown, but provocative, and deserves
o be explored in larger well-designed studies.
onclusions
sing previously published EUS characteristics, we identiﬁed CG
n 45% of the cases. EUS CG visualization and FNA could identify
nsuspected EPNI in pancreatic cancer. The clinical and prognostic
igniﬁcance of identifying CG and EPNI in pancreatic cancer needs
o be clariﬁed in larger studies with a prospective design.
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